American Cancer Society. SEER Cancer Stat Facts: Stomach Cancer [12/5/2022]. SEER 17 2012–2018. Available from: https://seer.cancer.gov/statfacts/html/stomach.html.

Giaquinto AN, Miller KD, Tossas KY, Winn RA, Jemal A, Siegel RL. Cancer statistics for African American/Black people 2022. CA Cancer J Clin. 2022;72(3):202–29. https://doi.org/10.3322/caac.21718. (Epub 2022/02/11).

Article  PubMed  Google Scholar 

Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori Seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol. 2012;175(1):54–9. https://doi.org/10.1093/aje/kwr288. (Epub 2011/11/17).

Article  PubMed  Google Scholar 

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180–90. https://doi.org/10.1016/S2214-109X(19)30488-7. (Epub 2019/12/22).

Article  PubMed  Google Scholar 

Varga MG, Butt J, Blot WJ, Le Marchand L, Haiman CA, Chen Y, et al. Racial differences in Helicobacter pylori CagA Sero-prevalence in a consortium of adult cohorts in the United States. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2020;29(10):2084–92. https://doi.org/10.1158/1055-9965.EPI-20-0525. (Epub 2020/08/29).

Article  Google Scholar 

Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk factors and incidence of gastric cancer after detection of helicobacter pylori infection: a large cohort study. Gastroenterology. 2020;158(3):527-36 e7. https://doi.org/10.1053/j.gastro.2019.10.019. (Epub 2019/10/28).

Article  CAS  PubMed  Google Scholar 

Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19(Suppl 1):S37-43 (Epub 1995/01/01).

PubMed  Google Scholar 

Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69(12):2113–21. https://doi.org/10.1136/gutjnl-2020-320839. (Epub 2020/03/25).

Article  PubMed  Google Scholar 

Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53(9):1244–9. https://doi.org/10.1136/gut.2003.034629. (Epub 2004/08/13).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L, Zhang Y, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 2019;366:l5016. https://doi.org/10.1136/bmj.l5016. Epub 2019/09/13 PubMed PMID: 31511230; PubMed Central PMCID: PMCPMC6737461 at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488–92. https://doi.org/10.1093/jnci/djs003. (Epub 2012/01/25).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saito D, Boku N, Fujioka T, Fukuda Y, Matsushima Y, Sakaki N, et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese Intervention Trial (JITHP-Study). A randomized multi-center trial. Gastroenterology. 2005;128(Suppl 2):A4.

Google Scholar 

Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA J Am Med Assoc. 2004;291(2):187–94. https://doi.org/10.1001/jama.291.2.187. (Epub 2004/01/15).

Article  CAS  Google Scholar 

Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut. 2012;61(6):812–8. https://doi.org/10.1136/gutjnl-2011-300154.

Article  CAS  PubMed  Google Scholar 

Zhou L, Lin S, Ding S, Huang X, Jin Z, Cui R, et al. Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study. Chin Med J (Engl). 2014;127(8):1454–8 (Epub 2014/04/26).

PubMed  Google Scholar 

Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst. 2000;92(23):1881–8 (Epub 2000/12/07).

Article  CAS  PubMed  Google Scholar 

Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372(9636):392–7. https://doi.org/10.1016/S0140-6736(08)61159-9. (Epub 2008/08/05).

Article  PubMed  Google Scholar 

Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085–95. https://doi.org/10.1056/NEJMoa1708423. (Epub 2018/03/22).

Article  CAS  PubMed  Google Scholar 

Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, et al. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial. Gastrointest Endosc. 2018;88(3):475-85 e2. https://doi.org/10.1016/j.gie.2018.05.009. (Epub 2018/05/26).

Article  PubMed  Google Scholar 

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. https://doi.org/10.1016/j.jbi.2008.08.010. (Epub 2008/10/22).

Article  PubMed  Google Scholar 

Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212–39. https://doi.org/10.1038/ajg.2016.563. (Epub 2017/01/11).

Article  PubMed  Google Scholar 

Feder R, Posner S, Qin Y, Zheng J, Chow SC, Garman KS. Helicobacter pylori-associated peptic ulcer disease: a retrospective analysis of post-treatment testing practices. Helicobacter. 2018;23(6):e12540. https://doi.org/10.1111/hel.12540. (Epub 2018/09/25).

Article  CAS  PubMed  Google Scholar 

Kumar S, Metz DC, Kaplan DE, Goldberg DS. Low rates of retesting for eradication of Helicobacter pylori infection after treatment in the veterans health administration. Clin Gastroenterol Hepatol. 2021;19(2):305-13 e1. https://doi.org/10.1016/j.cgh.2020.03.059. (Epub 2020/04/10).

Article  CAS  PubMed  Google Scholar 

Fan F, Wang Z, Li B, Zhang H. Effects of eradicating Helicobacter pylori on metachronous gastric cancer prevention: a systematic review and meta-analysis. J Eval Clin Pract. 2020;26(1):308–15. https://doi.org/10.1111/jep.13179. (Epub 2019/05/30).

Article  PubMed  Google Scholar 

El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, et al. Houston consensus conference on testing for Helicobacter pylori infection in the United States. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2018;16(7):992-1002 e6. https://doi.org/10.1016/j.cgh.2018.03.013. (Epub 2018/03/22).

Article  Google Scholar 

Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020;69(12):2093–112. https://doi.org/10.1136/gutjnl-2020-322368. (Epub 2020/10/03).

Article  PubMed  Google Scholar 

Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B, et al. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020;382(5):427–36. https://doi.org/10.1056/NEJMoa1909666. (Epub 2020/01/30).

Article  PubMed  Google Scholar 

He J, Hu W, Ouyang Q, Zhang S, He L, Chen W, et al. Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer. Cancer Lett. 2022;542:215764. https://doi.org/10.1016/j.canlet.2022.215764. (Epub 2022/06/03).

Article  CAS  PubMed  Google Scholar 

Dooyema SDR, Noto JM, Wroblewski LE, Piazuelo MB, Krishna U, Suarez G, et al. Helicobacter pylori actively suppresses innate immune nucleic acid receptors. Gut microbes. 2022. https://doi.org/10.1080/19490976.2022.2105102. (Epub 2022/07/30).

Article  PubMed  PubMed Central  Google Scholar 

Oster P, Vaillant L, McMillan B, Velin D. The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.899161. (Epub 2022/06/10).

Article  PubMed  PubMed Central  Google Scholar 

Shah S, Cappell K, Sedgley R, Pelletier C, Jacob R, Bonafede M, et al. Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016–2019. Sci Rep. 2023;13(1):1375. https://doi.org/10.1038/s41598-023-28200-3. (Epub 2023/01/26 Yadlapati is a consultant for Phathom Pharmaceuticals. Dr. Cappell, Mr. Sedgley, and Dr. Bonafede are employees of Veradigm. Dr. Pelletier and Dr. Jacob are employees of Phathom Pharmaceuticals).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2017;15(12):1833–43. https://doi.org/10.1016/j.cgh.2017.05.023. (Epub 2017/05/24).

Article  Google Scholar